Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Noninvasive Device Computes Blood Glucose Levels

By LabMedica International staff writers
Posted on 13 Sep 2010
Raman spectroscopy has been used to measure the amount of glucose in the tissue under the skin without the need to perform phlebotomy. More...


Raman spectroscopy is a technique used to study vibrational, rotational, and other low-frequency modes in a system. It relies on inelastic scattering of monochromatic light, usually from a laser in the visible, near infrared, or near ultraviolet range.

Patients undergoing the oral glucose tolerance test (OGTT) need to have their blood drawn at frequent intervals so that after ingestion of a glucose-rich solution, the level of glucose in the blood can be estimated. This test will determine how quickly glucose is cleared from the blood, an indicator of diabetes, insulin resistance, or reactive hypoglycemia. In a study of 10 healthy volunteers undergoing OGTT, at the Massachusetts Institute of Technology's (MIT) Spectroscopy Laboratory (Cambridge, MA, USA), blood concentrations of glucose were measured every 10 minutes using a clinical glucose analyzer (HemoCue, Inc., Lake Forest, CA, USA).

Raman spectra were collected every five minutes from the forearms of healthy Caucasian and Asian human volunteers undergoing the OGTT. For the excitation source, an 830 nm diode laser was used at an average power of 300 mW on a 1 mm2 skin spot. An f/1.8 spectrograph was coupled to a liquid nitrogen-cooled charge-coupled device for spectral dispersion and acquisition, respectively. A dynamic concentration correction (DCC) calibration method was applied to the Raman spectra results for correlation with the blood glucose results.

The Raman technique actually measures the glucose concentration in the interstitial fluid and not the blood. However, this calibration becomes more difficult immediately after the patient drinks the glucose solution because blood glucose soars rapidly, while it takes 5-10 minutes to see a corresponding surge in the interstitial fluid glucose levels. Therefore, interstitial fluid measurements do not give an accurate picture of what is happening in the bloodstream. To compare the two sets of results, the scientists used an algorithm that relates the two concentrations, allowing them to predict blood glucose levels from the glucose concentration in interstitial fluid. After the algorithm was applied, the results from the two sets of data were very similar.

The scientists reported that using DCC-calibrated Raman spectroscopy significantly boost the accuracy of blood glucose measurements with an average improvement of 15%, and up to 30% in some subjects. The study was published in the June 2010 issue of Analytical Chemistry.

Related Links:
Massachusetts Institute of Technology
HemoCue, Inc.



New
Gold Member
Automatic CLIA Analyzer
Shine i9000
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Collection and Transport System
PurSafe Plus®
Hemodynamic System Monitor
OptoMonitor
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Residual leukemia cells may predict long-term survival in acute myeloid leukemia (Photo courtesy of Shutterstock)

MRD Tests Could Predict Survival in Leukemia Patients

Acute myeloid leukemia is an aggressive blood cancer that disrupts normal blood cell production and often relapses even after intensive treatment. Clinicians currently lack early, reliable markers to predict... Read more

Immunology

view channel
Image: The simple blood marker can predict which lymphoma patients will benefit most from CAR T-cell therapy (Photo courtesy of Shutterstock)

Routine Blood Test Can Predict Who Benefits Most from CAR T-Cell Therapy

CAR T-cell therapy has transformed treatment for patients with relapsed or treatment-resistant non-Hodgkin lymphoma, but many patients eventually relapse despite an initial response. Clinicians currently... Read more

Pathology

view channel
Image: Determining EG spiked into medicinal syrups: Zoomed-in images of the pads on the strips are shown. The red boxes show where the blue color on the pad could be seen when visually observed (Arman, B.Y., Legge, I., Walsby-Tickle, J. et al. https://doi.org/10.1038/s41598-025-26670-1)

Rapid Low-Cost Tests Can Prevent Child Deaths from Contaminated Medicinal Syrups

Medicinal syrups contaminated with toxic chemicals have caused the deaths of hundreds of children worldwide, exposing a critical gap in how these products are tested before reaching patients.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.